Search

Theresa Racheal Cassino

from Ellicott City, MD
Age ~46
Get Report
Also known as:
Theresa R Cassino, Theresa Rachel Cassino, Theresa R Gouker, Theresa Cassimo, Toby R Gouker
Phone and address:
3582 Conchita Dr, Ellicott, MD 21042
(540) 961-6256
Related to:
Kymberly Devens GoukerMary J Gouker, 67Daniel R Cassino, 44Daniel A Gouker, 36Suzann M Lark, 71Cameron M Schmitt, 35Andrew Dell, 42Toby R Gouker, 68Christina I Gouker, 34Christopher D Cassino, 47
Connected to:
Christhian Cassino, 51Lance R Cassino, 78Amilcar B Cassio, 56Felipe N Cassio, 78Gary E Cassio, 65Sandra Cassio, 62Luke P Cassiol, 61Anthony J Cassioppi, 47Joseph J Cassioppi, 42Billy J Cassis, 43

Theresa Cassino Phones & Addresses

  • 3582 Conchita Dr, Ellicott City, MD 21042 (540) 961-6256
  • Cuyahoga Falls, OH
  • 7679 Pennsylvania Ave, Irwin, PA 15642 (724) 863-3576
  • North Huntingdon, PA
  • Pittsburgh, PA
  • Blacksburg, VA

Resumes

Resumes

Theresa Cassino Photo 1

Director, Project Management

View page
Location:
3582 Conchita Dr, Ellicott City, MD 21042
Industry:
Biotechnology
Work:
Emergent Biosolutions Aug 2017 - May 2018
Manager, Project Manager, Ciadm
Mapp Biopharmaceutical Inc Aug 2017 - May 2018
Director, Project Management
Emergent Biosolutions Aug 2016 - Aug 2017
Manager Program Management, External Development
Emergent Biosolutions Jun 2014 - Aug 2016
Project Manager
Triea Systems, Llc. Mar 2014 - Oct 2014
Advisory Team Member
Education:
Virginia Tech 2002 - 2006
Doctorates, Doctor of Philosophy, Chemical Engineering Virginia Tech 2000 - 2002
Master of Science, Masters, Chemical Engineering Rowan University 1996 - 2000
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Cell Culture
Western Blotting
Molecular Biology
Laboratory
Elisa
Fluorescence Microscopy
Biotechnology
Project Management
Stem Cells
Research
R&D
Rt Pcr
Validation
Life Sciences
Problem Solving
Confocal Microscopy
Immunofluorescence
Lifesciences
Science
Public Speaking
In Vitro
Mammalian Cell Culture
Microscopy
Mamillian Cell Culture
Pmp
Tissue Engineering
Oncology
Bioinformatics
In Vivo
Experimental Design
Technical Writing
Ms Project
Microsoft Office
Primary Cell Culture
Project Portfolio Management
Product Development
Teamwork
Pyrosequencing
In Cell Western
Regenerative Medicine
Biomedical Engineering
Research and Development
Presentations
Ms Office Suite
Project Management Software
Microsoft Project
Management
Government Project Management
Governmental Affairs
Interests:
Science and Technology
Languages:
English
Certifications:
Project Management Professional (Pmp)
Six Sigma Green Belt Ssgb
Microsoft Project 2016 Essential Training
Business Acumen For Project Managers
Become A Government Project Manager
Project Management Institute, License 1511299
License 1511299
Theresa Cassino Photo 2

Theresa Cassino

View page

Publications

Us Patents

Methods For Predicting A Patient's Response To Egfr Inhibitors

View page
US Patent:
20100311084, Dec 9, 2010
Filed:
Jun 7, 2010
Appl. No.:
12/795286
Inventors:
Stacey Brower - Pittsburgh PA, US
Shara D. Rice - Pittsburgh PA, US
Theresa R. Cassino - Pittsburgh PA, US
Lahari Sakhamuri - Pittsburgh PA, US
Heather M. Buechel - Pittsburgh PA, US
Lauren M. Hancher - Pittsburgh PA, US
Assignee:
PRECISION THERAPEUTICS, INC. - Pittsburgh PA
International Classification:
G01N 33/574
US Classification:
435 723
Abstract:
The present invention provides methods for individualizing chemotherapy for cancer treatment, and particularly for evaluating a patient's responsiveness to one or more epidermal growth factor receptor (EGFR) inhibitors prior to treatment with such agents. Particularly, the invention provides an in vitro chemoresponse assay for predicting a patient's response to a monoclonal EGFR antibody, such as cetuximab. The method generally comprises culturing malignant cells from a patient's specimen (e.g., biopsy specimen), contacting the cultured cells with a monoclonal EGFR antibody that is a candidate treatment for the patient, and evaluating the cultured cells for a response to the drug. In certain embodiments, monolayer(s) of malignant cells are cultured from explants prepared by mincing tumor tissue, and the cells of the monolayer are suspended and plated for chemosenstivity testing. The in vitro response to the drug as determined by the method of the invention is correlative with the patient's in vivo response upon receiving the monoclonal EGFR antibody during chemotherapeutic treatment (e.g., in combination with other standardized or individualized chemotherapeutic regimen).
Control profile
Theresa Racheal Cassino from Ellicott City, MD, age ~46 Get Report